Turkish Version of The Diabetes Quality of Life Brief Clinical Inventory Validity and Reliability

Completed

• Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus; Diabetes Mellitus, Type 2
• Interventions: Other: Questionnaire

• Registration Number: NCT05407454
• Lead Sponsor: İlke KARA, PT

Brief Summary

This study aims to develop Turkish version of the Diabetes Quality of Life Brief Clinical Inventory (DQL-BCI) and to perform validity and reliability evaluations.

Detailed Description

The study will be carried out in two phases: DQL-BCI will be translated into Turkish and adapted to the cultural context, and the reliability and validity of the Turkish version of DQL-BCI will be investigated. The translation process will be performed in accordance with generally accepted international principles of translation and cultural adaptation of measurement tools. At least 150 subjects with type 2 diabetes will complete the Turkish version of DQL-BCI, the EQ-5D-3L questionnaire and the SF-12 quality of life questionnaire. The examination will provide information about the reliability and the construct validity of the studied tool.

Study Timeline

• Study First Submitted: 2022-06-02
• Study First Submitted QC: 2022-06-02
• Study Start: 2022-06-07
• Study First Posted: 2022-06-07
• Primary Completion: 2022-07-07
• Study Completion: 2022-08-07
• Status Verified: 2022-09
• Last Update Submitted: 2022-09-12
• Last Update Posted: 2022-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Aged between 18-65 years old
• Diagnosed with diabetes for one year or more (Type 1 or Type 2)
• Literacy
• Being on at least one anti-diabetes medication

Exclusion Criteria

• Not willing to participate in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Study Group	Questionnaire	Patients with diabetes (all types)

Primary Outcome Measures

Name	Time	Method
The Diabetes Quality of Life - Brief Clinical Inventory	1 week	The questionnaire consists of 15 questions, with no grouping into subscales or domains. Items are in two general formats. The first format is about the frequency of negative impacts of diabetes or odiabetes treatment and provides response options from "never" to "all the time". The second format is about the satisfaction with the treatment and QoL, and patients provide answers by selecting from "very satisfied" to "very dissatisfied". Answers to each question correspond to a score of 1-5, and 1 is the lowest score of a given parameter and 5 is the highest. The total score is the sum of scores of individual questions. The scoring ranges from 15 (the worst assessment of QoL) to 75 points (the best assessment of QoL).

Trial Locations

Locations (1)

Bitlis Eren University; 🇹🇷 Bitlis, Turkey